share_log

Clearmind Medicine Announces Institutional Review Board Approval For FDA Clinical Trial Of CMND-100 At Second Clinical Site In Alcohol Use Disorder

Clearmind Medicine Announces Institutional Review Board Approval For FDA Clinical Trial Of CMND-100 At Second Clinical Site In Alcohol Use Disorder

Clearmind Medicine宣布已获得机构审查委员会批准,在酒精滥用障碍的第二个临床试验站点进行CMND-100的FDA临床试验
Benzinga ·  2024/10/10 08:12

Clearmind Medicine Announces Institutional Review Board Approval For FDA Clinical Trial Of CMND-100 At Second Clinical Site In Alcohol Use Disorder

Clearmind Medicine宣布CMND-100在第二临床试验点获得FDA对酒精滥用障碍的临床试验机构审查委员会批准

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发